Corcept Therapeutics Q3 EPS $0.31 Beats $0.2 Estimate, Sales $81.505M Beat $78M Estimate

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.2 by 55 percent. This is a 40.91 percent increase over earnings of $0.22 per share from

Benzinga · 11/07/2019 22:35

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.2 by 55 percent. This is a 40.91 percent increase over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $81.505 million which beat the analyst consensus estimate of $78 million by 4.49 percent. This is a 26.47 percent increase over sales of $64.445 million the same period last year.